WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 Citi Global Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. Eastern Time.

image for news Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference

Navitas Semiconductor to Participate in Upcoming Investor Event — Neutral

NVTS   GlobeNewsWire — November 17, 2025

TORRANCE, Calif. , Nov. 17, 2025 (GLOBE NEWSWIRE) -- Navitas Semiconductor, an industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, has announced participation in the following upcoming investor event:

image for news Navitas Semiconductor to Participate in Upcoming Investor Event

Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations

image for news Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth's Novel AI-Powered Breast Cancer Detection Workflow

Candel Therapeutics to Host Virtual R&D Event on December 5, 2025 — Neutral

CADL   GlobeNewsWire — November 17, 2025

NEEDHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced it will host a virtual Research and Development (R&D) Event from 11:00 am – 1:45 pm ET on Friday, December 5, 2025.

image for news Candel Therapeutics to Host Virtual R&D Event on December 5, 2025

MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of its New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for gedatolisib in hormone receptor positive (“HR+”), human epidermal growth factor receptor 2 negative (“HER2-”), advanced breast cancer (“ABC”). The NDA was submitted under the FDA's Real-Time Oncology Review (“RTOR”) program, which is intended to facilitate shorter regulatory review periods. Gedatolisib previously received both Breakthrough Therapy and Fast Track designations based on promising preliminary clinical data. The …

image for news Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Neutral

TELA   GlobeNewsWire — November 17, 2025

MALVERN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of (i) restricted stock units covering 30,200 shares of its common stock to seventeen newly-hired employees and (ii) an option to purchase 25,000 shares of its common stock to one employee, with a grant date of November 10, 2025 (the "Grant Date"). The equity awards were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception …

image for news TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RADIANT LOGISTICS ANNOUNCES RENEWAL OF ITS STOCK REPURCHASE PROGRAM — Neutral

RLGT   PRNewsWire — November 17, 2025

RENTON, Wash. , Nov. 17, 2025 /PRNewswire/ -- Radiant Logistics, Inc. (NYSE American: RLGT), a technology-enabled global transportation and value-added logistics services company, today announced that its board of directors has authorized the repurchase of up to five million shares of the Company's common stock through December 31, 2027.

image for news RADIANT LOGISTICS ANNOUNCES RENEWAL OF ITS STOCK REPURCHASE PROGRAM

Kfar Saba, Israel, Nov. 17, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced a significant purchase order for its DefendAir anti-drone defense systems from a Dutch distributor, one of Europe's largest integrators.

image for news ParaZero Strengthens European Anti-Drone Capabilities with a Significant Purchase Order for DefendAir Systems from Leading Dutch Defense Distributor

Private equity firm Thoma Bravo has made an offer to acquire Clearwater Analytics , people familiar with the matter said on Monday.

image for news Exclusive: Buyout firm Thoma Bravo has offered to buy Clearwater Analytics, sources say

Alphabet: Berkshire Buys, Happy To Finally Just Hold (Rating Downgrade) — Neutral

BRK-A  BRK-B  GOOG  GOOGL   Seeking Alpha — November 17, 2025

Alphabet Inc. remains fundamentally strong, with robust growth prospects and a fortress balance sheet supporting continued optimism. GOOGL's valuation is no longer the cheapest, as recent price appreciation has priced in much of the next 12 months' growth. Wall Street sentiment has turned ultra-bullish, with many analysts raising price targets above $300 per share, reflecting confidence in cloud and search resilience.

image for news Alphabet: Berkshire Buys, Happy To Finally Just Hold (Rating Downgrade)

MILWAUKEE--(BUSINESS WIRE)--The Manitowoc Company, Inc. (NYSE: MTW), (the “Company' or “Manitowoc”) announced today that it was recognized again as one of the 2025 “Best for Vets” Employers by Military Times, earning an overall ranking of #48 and #3 in the Manufacturing category. The 2025 recipients list can be viewed on Military Times website. Aaron H. Ravenscroft, President and Chief Executive Officer of The Manitowoc Company, Inc. said, “We are honored to once again be recognized by Military.

image for news Manitowoc Recognized Again as One of 2025 “Best for Vets” Employers by Military Times

Southfield, Michigan, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) has been named a 2025 Top Workplace in Michigan by the Detroit Free Press, ranking #2 among large companies, the same as last year. This marks our 14th consecutive year earning this honor.

image for news Credit Acceptance Named a 2025 Top Workplace in Michigan by the Detroit Free Press

New York, New York--(Newsfile Corp. - November 17, 2025) - If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ: CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=177791&wire=5&utm_campaign=7 or contact Joseph E. Levi, Esq.

image for news CYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics, Incorporated Investors - Lead Plaintiff Deadline November 17, 2025

NextNRG Inc. (NXXT) Q3 2025 Earnings Call Transcript — Neutral

NXXT   Seeking Alpha — November 17, 2025

NextNRG Inc. ( NXXT ) Q3 2025 Earnings Call November 17, 2025 8:30 AM EST Company Participants Sharon Cohen Michael Farkas - Executive Chairman & CEO Joel Kleiner Presentation Operator Greetings. Welcome to the NextNRG Third Quarter 2025 Earnings Results Conference Call.

image for news NextNRG Inc. (NXXT) Q3 2025 Earnings Call Transcript

XPeng Inc. (XPEV) Q3 2025 Earnings Call Transcript — Neutral

XPEV   Seeking Alpha — November 17, 2025

XPeng Inc. ( XPEV ) Q3 2025 Earnings Call November 17, 2025 8:00 AM EST Company Participants Alex Xie - Head of Investor Relations He Xiaopeng - Co-founder, Chairman & CEO Jiaming Wu - Vice President of Finance & Accounting Charles Zhang - Vice President of Corporate Finance and BW Projects Gui Hongdi - Honorary Vice Chairman of the Board & Co-President Conference Call Participants Tim Hsiao - Morgan Stanley, Research Division Y.C. Lai - JPMorgan Chase & Co, Research Division Ming-Hsun Lee - BofA Securities, Research Division Tina Hou - Goldman Sachs Group, Inc., Research Division Pingyue Wu - …

image for news XPeng Inc. (XPEV) Q3 2025 Earnings Call Transcript

TotalEnergies SE (TTE) M&A Call Transcript — Neutral

TTE   Seeking Alpha — November 17, 2025

TotalEnergies SE ( TTE ) M&A Call November 17, 2025 7:00 AM EST Company Participants Patrick Pouyanné - Chairman & CEO Stephane Michel - President of Gas, Renewables & Power Conference Call Participants Biraj Borkhataria - RBC Capital Markets, Research Division Bertrand Hodee - Kepler Cheuvreux, Research Division Irene Himona - Sanford C. Bernstein & Co., LLC.

image for news TotalEnergies SE (TTE) M&A Call Transcript

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Avantor, Inc. ("Avantor, Inc." or the "Company") (NYSE: AVTR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Avantor, Inc. investors who were adversely affected by alleged securities fraud between March 5, 2024 and October 28, 2025.

image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 29, 2025 in Avantor, Inc. Lawsuit – AVTR

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in James Hardie Industries plc. ("James Hardie Industries plc.

image for news Levi & Korsinsky Reminds James Hardie Industries plc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 23, 2025 – JHX

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Baxter International, Inc. investors who were adversely affected by alleged securities fraud between February 23, 2022 and July 30, 2025.

image for news Levi & Korsinsky Notifies Baxter International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – BAX

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fortinet, Inc. ("Fortinet, Inc." or the "Company") (NASDAQ: FTNT) of a class action securities lawsuit.

image for news Shareholders that lost money on Fortinet, Inc.(FTNT) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More